Gri Bio

(NASDAQ) GRI

Current Price$2.27

Market Cap$3.98M

Since IPO (2023)-100%

5 Year-100%

1 Year-94%

1 Month-0%

Gri Bio Financials at a Glance

Market Cap

$3.98M

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.91M

EPS (TTM)

-$79.55

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$2.27

Volume

51,046

Open

$2.33

Price

$2.27

Volume

51,046

Open

$2.33

Previous Close

$2.25

Daily Range

$2.20 - $2.33

52-Week Range

$1.97 - $80.36

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$2.27

Volume

51,046

Open

$2.33

Previous Close

$2.25

Daily Range

$2.20 - $2.33

52-Week Range

$1.97 - $80.36

Estimated Earnings Date

Aug 13, 2026

GRI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gri Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

W. Marc Hertz, PhD

Website

www.gribio.com

Headquarters

La Jolla, CA 92037, US

GRI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-186%

Return on Capital

-1%

Return on Assets

-96%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.98M

Shares Outstanding

1.77M

Volume

51.05K

Avg. Volume

82.73K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$11.98M

EBITDA

-$11.97M

Operating Cash Flow

-$10.19M

Capital Expenditure

-$3.00K

Free Cash Flow

-$10.19M

Cash & ST Invst.

$8.23M

Total Debt

$71.00K

Gri Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.98M

N/A

Market Cap/Employee

$1.33M

N/A

Employees

N/A

Net Income

-$2.00M

+34.4%

EBITDA

-$2.00M

+34.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$11.05M

+236.7%

Total Debt

$58.00K

-46.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$58.00K

+16.0%

Return on Assets

-96.20%

N/A

Return on Invested Capital

-1.04%

N/A

Free Cash Flow

-$3.69M

-72.8%

Operating Cash Flow

-$3.69M

-112.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCNS Pharmaceuticals, Inc.

CNSPCNS Pharmaceuticals, Inc.$4.89+3.60%

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$1.51-4.43%

BDRXBiodexa Pharmaceuticals Plc

BDRXBiodexa Pharmaceuticals Plc$3.03-1.69%

SILOSilo Pharma, Inc.

SILOSilo Pharma, Inc.$6.63+2.95%

SXTP60 Degrees Pharmaceuticals, Inc.

SXTP60 Degrees Pharmaceuticals, Inc.$1.36-1.45%

ABPAbpro Corporation

ABPAbpro Corporation$0.52+0.00%

GNPXGenprex, Inc.

GNPXGenprex, Inc.$0.64-2.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About GRI

What is the current price of Gri Bio?

Gri Bio is trading at $2.25 per share.

What is the 52-week range for Gri Bio?

Over the past 52 weeks, Gri Bio has traded between $1.97 and $80.36.

How much debt does Gri Bio have?

As of the most recent reporting period, Gri Bio reported total debt of $58.00K.

How much cash does Gri Bio have on hand?

Gri Bio reported $11.05M in cash and cash equivalents in its most recent financial results.

What is Gri Bio’s dividend yield?

Gri Bio does not currently have a dividend yield.

Gri Bio

Gri Bio Financials at a Glance

GRI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Gri Bio

GRI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Gri Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GRI

What is the current price of Gri Bio?

What is the 52-week range for Gri Bio?

How much debt does Gri Bio have?

How much cash does Gri Bio have on hand?

What is Gri Bio’s dividend yield?

Premium Investing Services